Radiopharm Theranostics
RADX
7 hedge funds and large institutions have $2.06M invested in Radiopharm Theranostics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 | -$637K | |
| 2 | -$248K | |
| 3 | -$76K | |
| 4 |
Jane Street
New York
|
-$75.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$55.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Silverarc Capital Management
Boston,
Massachusetts
| $806K |
|
|||
|
SCM
2
Stonepine Capital Management
Bend,
Oregon
| $739K |
|
|||
3
HSBC Holdings
London,
United Kingdom
| $265K |
|
|||
|
RP
4
Regal Partners
Sydney, NSW,
Australia
| $173K |
|
|||
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $68.8K |
|
|||
|
6
UBS Group
Zurich,
Switzerland
| $12.9K |
|
|||
7
RhumbLine Advisers
Boston,
Massachusetts
| $519 |
|
|||
|
VF
8
Virtu Financial
New York
| – |
|
|||
|
9
Jane Street
New York
| – |
|
|||
|
MG
10
Marex Group
London,
| – |
|
|||
|
SWP
11
Strategic Wealth Partners
Independence,
Ohio
| – |
|
RADX Hedge Fund Activity: Q1 2026 in Review
7 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Radiopharm Theranostics (RADX) for Q1 2026, worth a combined $2.06M — down 44% from $3.67M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RADX and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was RhumbLine Advisers, adding an estimated $562. The largest seller was HSBC Holdings, cutting an estimated $637K.
- 7 institutional investors held Radiopharm Theranostics (RADX) as of Q1 2026, down from 11 in Q4 2025.
- Funds reported $2.06M of Radiopharm Theranostics stock for Q1 2026, down 44% quarter-over-quarter.
- 0 funds opened new Radiopharm Theranostics positions in Q1 2026 and 4 closed out, a net change of -4 holders.
- The largest Radiopharm Theranostics buyer in Q1 2026 was RhumbLine Advisers, an estimated $562 added.
- The largest Radiopharm Theranostics seller in Q1 2026 was HSBC Holdings, an estimated $637K sold.
Based on aggregated 13F filings for Q1 2026.